MELBOURNE, Australia, May 10, 2012 /PRNewswire/ -- Global regenerative medicine company Mesoblast Limited (ASX: MSB) today announced the appointment of Dr Ben-Zion Weiner, Special Adviser to

FRAZER, Pa., May 4, 2012 /PRNewswire/ -- Teva Women's Health today announced new data from the Company's expanding women's health franchise will be featured at the 60th Annual Clinical Meeting

According to a recent study, people who received injections of the multiple sclerosis (MS) drug interferon beta-1a directly after noticing signs of possible MS were less likely to progress into definite MS compared to those who switched to interferon beta-1a from placebo.

ANN ARBOR, Mich., March 14, 2012 /PRNewswire/ -- Synthetic Biologics, Inc.

NEW YORK, Nov.